A Phase II Study Of Triapine In Combination With Cisplatin Esophageal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2013
At a glance
- Drugs Cisplatin (Primary) ; OCX 191 (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 28 Jul 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2005 New trial record.